All News

Article

How are RA patients doing using telemedicine/virtual care?

Janet Pope, MD, MPH, FRCPC Dec 02, 2020

Rheumatologists switched their practices overnight from primarily in person to nearly all virtual care as COVID-19 pandemic geared up in March 2020 and then to a blend of in person and virtual care. How are RA patients doing?

Article

New ACR RA Guidelines and Practice Changing Abstracts: RA Panel

Jonathan Kay, MD Nov 24, 2020

Dr. Jonathan Kay leads an international panel discussion on the new ACR RA guidelines and several practice-changing abstracts presented at the 2020 ACR meeting. Panelists include Dr. Kathryn Dao, Dr. Eric Dein, Dr. Meral El Ramahi, Dr. Richard Conway and Dr. Sheila Reyes.

#BestACR20Tweets RT @ejdein1 : Draft #ACR20 Rx Recs for RA: Treatment recommendations for Hepatitis B - highest risk is for RTX for reactivation! @RheumNow. https://t.co/JvYm9Ii6PV https://t.co/qjXBuzUug6

https://bit.ly/2JzwaCQ

ACR has released 2 free powerpoint slide decks featuring select RA and SLE abstracts from #ACR20 (a 3rd late-breaking slide deck is yet to come!). Download here>> https://t.co/CiNH0xfs7J

https://bit.ly/2I46Ep7

#BestACR20Tweets RT @ejdein1 : Draft #ACR20 Rx Recs for RA: MTX is conditionally recommended with NORMAL LFTs and no advanced fibrosis. Role of HCQ for NALFD has been suggested at ACR, but not enough for mod-high disease activity @RheumNow. https://t.co/XswkhT1f66 https://t.co/bdngrnY9hc

https://bit.ly/3fTuKzn

#BestACR20Tweets RT @MeralElRamahiMD : Switching or adding a DMARD in pts w/ mod-high dz RA activity ; hx of previous serious infection w/in the past 12 mos as opposed to starting/increasing GCs is conditionally recommended per draft recs of new ACR RA treatment guidelines.

#BestACR20Tweets RT @KDAO2011 : Very strong push by #ACR20 to recc MTX in most RA patient scenarios including RA ILD, RA nodules, NAFLD in new RA guidance document @rheumnow

Citrulline Reactive B Cells Present in Lungs of Risk, Early RA: Richard Conway ( @RichardPAConway) discusses ACR abstract #1445 presented #ACR20 https://t.co/WjcBPay86P https://t.co/JnUVss0FDK

https://bit.ly/37rMhdV

#BestACR20Tweets RT @DrMiniDey : Patient-physician discordance seen in ~30% RA patients starting #DMARDs - ↑Patient-reported pain; functional impairment assoc. w/ discordance - Patient-centric treatment discussions needed to reduce discordance Abs#1978 https://t.co/uTJehn5Qs5 https://t.co/289d3VsE22

https://acrabstracts.org/abstract/prevalence-and-factors-associated-with-patien…

RA Risk Factors and Early RA: Dr. Jeffrey Sparks ( @jeffsparks) and Dr. Janet Pope ( @Janetbirdope) #ACR20 https://t.co/vN7Dt60R4W https://t.co/K5vAhEQfks

https://bit.ly/3lp0xsU

Dr. Kay leads an internat'l panel of rheums to elicit their opinions on key abstracts at #ACR20. Panelists: Dr. David Liew, Dr. Eric Dein, Dr. Meral El Ramahi, Dr. Richard Conway, Dr. Sheila Reyes and Dr. Jeffrey Sparks. https://t.co/Jg6QiswnnJ https://t.co/UAqiN3F734

https://bit.ly/2JkgsM8

#BestACR20Tweets RT @MeralElRamahiMD : Wonder if you can predict development of clinical RA in those at risk either w/ a - +RF or +CCP - Relevant sxs w/ or w/o abs - 1st deg relatives do RA pts? #ACR20 https://t.co/xVZHxL35UY

https://bit.ly/3qd2Hje

#BestACR20Tweets RT @RADoctor: Adjuvant #herpeszoster vaccine (Shingrix) not effective for 25% of JAKi-treated RA pts (n=40) for antibody response (T cell response usually worse, not reported). Is better than nothing good enough? Maybe we need to hold JAKi briefly?

New ACR RA Guidelines and Practice Changing Abstracts #ACR20 https://t.co/3lGSUDks8F

https://bit.ly/3q6Ruk2

Check this out! Can PT-CDAI in Telemedicine be Used for Care in RA? Dr. Eric Dein ( @ejdein1) #ACR20 https://t.co/dAgYOFMMJC https://t.co/QV02h171yP

https://bit.ly/2UW8Vp6

"Erosions on X-ray: can we delegate this to the computers?" by Dr. David Liew ( @drdavidliew) #ACR20 https://t.co/YvKjAWebT9 https://t.co/RS4P29UVym

https://bit.ly/32GZoGF

Rheumatoid Arthritis and ILD: Dr. Janet Pope ( @Janetbirdope) interviews Dr. Jeffrey Sparks ( @jeffsparks) about abstracts #0392, #0491, #1198 and #0489 presented at #ACR20. https://t.co/e6HI1SqqSf https://t.co/naXAo8nc1g

https://bit.ly/2J6oVma

#BestACRO20Tweets "RT @RHEUMarampa : Large cohort of older RA pts newly rx w/HCQ or MTX: 👉~2-fold ⬆ risk of VTE – both PE and DVT- among patients newly treated with MTX vs. HCQ. @RheumNow #ACR20 abs#2000 @DanielHSolomon https://t.co/4gK7hwdhIr" https://t.co/JsGBFrp7Hl

https://bit.ly/2UXNN1V

#BestACR20Tweets RT @ejdein1 : Worth checking out the #ACR20 image competition. Here's an image of cerebral toxoplasmosis during ADA treatment for RA https://t.co/JH07pMjvRe https://t.co/H9LHwiw4xL

https://bit.ly/3ftm0Qg

#BestACR20Tweets RT @DrMiniDey : Late breaking: in older #rheumatoidarthritis patients, those taking MTX have 2x risk of #VTE compared to those on HCQ. Important to consider #thromboembolic risk factors when starting new RA treatment. Abs#2000 #ACR20 https://t.co/lMYlXgaHyE https://t.co/0Fdone9yb3

https://bit.ly/2J8kxTz

Topics

All News

How are RA patients doing using telemedicine/virtual care?

New ACR RA Guidelines and Practice Changing Abstracts: RA Panel

Do you get our email newsletter?